Press release

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (OR TO US PERSONS (AS DEFINED IN
REGULATION S UNDER THE US SECURITIES ACT OF 1933, AS AMENDED), AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION
IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER
OF SECURITIES IN ANY JURISDICTION


Antwerp, February 7, 2025, 13:00 CET – Regulated information




Final results of the capital increase
With the successful completion of the public offering to subscribe to the capital increase
and the private placement of Scrips, both existing shareholders and new investors have
subscribed to 100% of the offering, representing a total amount of EUR 247 million.


“The successful completion of this capital increase is a crucial event in Gimv's 45-year
history. It marks an important starting point as these funds strengthen our capital to support
our accelerated growth strategy with the ambition to double our portfolio and to create
additional value for our shareholders. We would like to thank our existing and new
shareholders for their support and confidence. Now is the time to invest in our industry and
economy. Gimv is more than ever ready to put these additional funds to work by doing
what we do best: building leading companies.”

CEO Koen Dejonckheere & CFO Kristof Vande Capelle


The 5,009,632 unexercised Preferential Rights (in With the successful completion of both the
the form of Scrips) were offered for sale on public offering and the Scrips Private
February 7, 2025 to Belgian and international Placement, existing shareholders and new
investors by way of a private placement in the investors now have subscribed for 100% of the
form of an accelerated bookbuilding (in other New Shares offered for a total amount of EUR
words, an accelerated private placement with 246,794,370. The gross proceeds of the offer
composition of an order book) (the “Scrips hence equal the targeted maximum of EUR
Private Placement”). 246,794,370 and the net proceeds of the offer
are approximately EUR 242.1 million (after
Buyers of the Scrips have irrevocably
deduction of estimated costs and expenses).
committed themselves to exercise the Scrips
and subscribe for 1,252,408 New Shares at the
Upon finalization of this capital increase and
same subscription price and the same
delivery of the New Shares, WorxInvest's
subscription ratio as the subscription through
shareholding in Gimv will increase from 29.9% to
the exercise of Preferential Rights, i.e. 1 New
32.3%, pursuant to the implementation of their
Share (at EUR 34.50 per New Share) for 4
subscription commitment.
Preferential Rights.




Gimv NV - Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - www.gimv.com 1
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (OR TO US PERSONS (AS DEFINED IN
REGULATION S UNDER THE US SECURITIES ACT OF 1933, AS AMENDED), AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION
IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER
OF SECURITIES IN ANY JURISDICTION


Antwerp, February 7, 2025, 13:00 CET – Regulated information

Press release

The net proceeds from the sale of the Scrips,
after deducting the costs, expenses and Note: Unless otherwise stated in this press release,
charges incurred by the Company in the the capitalized terms in this press release shall have
the meaning defined in the Prospectus prepared
context of the Scrips Private Placement (the with respect to the Offer.
“Net Proceeds of the Scrips”), amount to EUR
0.48 per unexercised (or qualified as such)
Preferential Right. The Company expects that
this amount shall be paid to these holders as
from February 12, 2025. About Gimv

Delivery of the New Shares is expected to take Gimv is a European investment company, listed
place on February 11, 2025. The New Shares will on Euronext Brussels and a member of the
be tradable on the regulated market of Euronext BEL ESG Index. With over 40 years'
Euronext Brussels, in principle as from the same experience in private equity, Gimv currently has
date. an investment portfolio of more than EUR 1.7
billion. The portfolio contains around 60 portfolio
The trading of the shares of the Company on companies, with combined turnover of EUR 4.0
the regulated market of Euronext Brussels has billion and more than 20,000 employees.
been suspended, at the Company’s request,
as from the opening of the markets on February As a recognized market leader in selected
7, 2025 until shortly after the publication of this investment platforms, Gimv identifies
press release. With this phase being successfully entrepreneurial, innovative companies with high
completed, the Company requested to lift this growth potential and supports them in their
suspension. transformation into market leaders. Gimv's five
investment platforms are Consumer, Healthcare,
KBC Securities and Belfius Bank (in cooperation Life Sciences, Smart Industries and Sustainable
with Kepler Cheuvreux) act as Joint Global Cities. Each platform works with an experienced
team across Gimv’s home markets of Benelux,
Coordinators and Joint Bookrunners for this
France and DACH, supported by an extended
transaction. Bank Degroof Petercam, BNP
international network of experts.
Paribas Fortis and ING Belgium act as Joint
Bookrunners.
Further information on Gimv can be found on
www.gimv.com.
The prospectus is available on Gimv’s website:
https://www.gimv.com/en/capital-increase.
For further information please contact:

Kristof Vande Capelle, CFO
T +32 3 290 22 17
kristof.vandecapelle@gimv.com




Gimv NV - Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - www.gimv.com 2
Press release

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (OR TO US PERSONS (AS DEFINED IN
REGULATION S UNDER THE US SECURITIES ACT OF 1933, AS AMENDED), AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION
IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER
OF SECURITIES IN ANY JURISDICTION


Antwerp, February 7, 2025, XX:XX CET – Regulated information

Disclaimer

This document is not for release, distribution or publication, whether directly or indirectly and whether in whole or in part, in or
into the United States (or to US Persons (as defined below), Canada, Australia, South Africa or Japan or any other jurisdiction
where to do so would constitute a violation of the relevant laws of such jurisdiction.

This document is for information purposes only and are not intended to constitute, and should not be construed as, an offer
to sell or a solicitation of any offer to buy the securities of Gimv NV (the Company, and such securities, the Securities) in or into
the United States, Canada, Australia, South Africa or Japan or in any other jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration, exemption from registration or qualification under the securities laws of such jurisdiction.

This document is not for publication or distribution, directly or indirectly, in or into the United States. This document is not an
offer of securities for sale into the United States. The Securities have not been and will not be registered under the U.S. Securities
Act of 1933, as amended, (the “Securities Act”) or with any securities regulatory authority of any state or other jurisdiction in
the United States, and may not be offered or sold in or into the United States or to or by US Persons (as defined in Regulation S
under the Securities Act (“Regulation S”) (“US Persons”) absent registration or an exemption from, or in a transaction not subject
to, the registration requirements of the Securities Act and applicable state securities laws and in a manner which would not
require the Company to register under the US Investment Company Act of 1940, as amended (the “Investment Company
Act”). The Securities are being offered and sold: (i) inside the United States only to persons reasonably believed to be both
“qualified institutional buyers” (“QIBs”), as defined in Rule 144A (“Rule 144A”) under the Securities Act and “qualified
purchasers” (“QPs”), as defined in Section 2(a)(51) of the Investment Company Act in reliance on Section 4(a)(2) under the
Securities Act and only by persons that have executed and timely returned a US Investor Letter in the form set forth in Appendix
1 of the prospectus prepared by the Company in the context of the offer of Securities; and (ii) outside the United States to
persons who are not US Persons in offshore transactions (as defined in Regulation S) in reliance on Regulation S. No public
offering of Securities is being made in the United States.

In the United Kingdom, this document and any other materials in relation to the Securities is only being distributed to, and is
only directed at, and any investment or investment activity to this document relate is available only to, and will be engaged
in only with, "qualified investors" (as defined in the meaning of the Prospectus Regulation EU 2017/1129 as it forms part of the
law of the United Kingdom) and who are (i) persons having professional experience in matters relating to investments who fall
within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (the “Order”); or (ii) persons falling within Article 49(2)(a) to (d) of the Order, i.e., high net worth
companies, unincorporated associations, etc. (all such persons together being referred to as relevant persons). Any invitation,
offer or agreement to subscribe for, purchase or otherwise acquire securities will be engaged in only with relevant persons.
Persons who are not relevant persons should not take any action on the basis of this document and should not act or rely on
it.

The Company has not authorised any offer to the public of Securities in any Member State of the European Economic Area
other than Belgium. With respect to any Member State of the European Economic Area, other than Belgium, (each a “Relevant
Member State”), no action has been undertaken or will be undertaken to make an offer to the public of Securities requiring
publication of a prospectus in any Relevant Member State. As a result, the Securities may only be offered in Relevant Member
States (i) to any legal entity which is a qualified investor as defined in the Prospectus Regulation; or (ii) in any other
circumstances falling within Article 1(4) of the Prospectus Regulation. For the purpose of this paragraph, the expression offer
of securities to the public (and related expressions) means the communication in any form and by any means of sufficient
information on the terms of the offer and the Securities to be offered so as to enable the investor to decide to purchase or
subscribe for the Securities and the expression Prospectus Regulation means Regulation (EU) 2017/1129 and includes any
relevant delegated regulations.




Gimv NV - Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - www.gimv.com 3
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (OR TO US PERSONS (AS DEFINED IN
REGULATION S UNDER THE US SECURITIES ACT OF 1933, AS AMENDED), AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION
IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER
OF SECURITIES IN ANY JURISDICTION


Antwerp, February 7, 2025, XX:XX CET – Regulated information

Press release

No action has been taken by the Company that would permit an offer of Securities or the possession or distribution of this
document or any other offering or publicity material relating to such Securities in any jurisdiction where action for that purpose
is required.

The release, publication or distribution of this document in certain jurisdictions may be restricted by law and therefore persons
in such jurisdictions into which they are released, published or distributed, should inform themselves about, and observe, such
restrictions.

This document may include statements, including the Company's financial and operational medium-term objectives that are,
or may be deemed to be, ''forward-looking statements''. These forward-looking statements may be identified by the use of
forward-looking terminology, including the terms ''believes'', ''estimates'', ''plans'', ''projects'', ''anticipates'', ''expects'', ''intends'',
''may'', ''will'' or ''should'' or, in each case, their negative or other variations or comparable terminology, or by discussions of
strategy, plans, objectives, goals, future events or intentions. Forward-looking statements may and often do differ materially
from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are
subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business,
results of operations, financial position, liquidity, prospects, growth or strategies. Forward-looking statements speak only as of
the date they are made.

Each of the Company, as well as KBC Securities NV and Belfius Bank NV/SA (acting together with its subcontractors Kepler
Cheuvreux SA and Kepler Cheuvreux (Suisse) SA) and Bank Degroof Petercam NV/SA, BNP Paribas Fortis SA/NV and ING Bank
NV (together, the “Underwriters”) and their respective affiliates expressly disclaims any obligation or undertaking to update,
review or revise any forward-looking statement contained in this document whether as a result of new information, future
developments or otherwise.

The Underwriters are acting exclusively for the Company and no one else in connection with any offering of Securities. They
will not regard any other person as their respective clients in relation to any offering of Securities and will not be responsible to
anyone other than the Company for providing the protections afforded to their respective clients nor for providing advice in
relation to any offering of Securities, the contents of this document or any transaction, arrangement or other matter referred
to herein. None of the Underwriters or any of their respective affiliates or any of their respective directors, officers, employees,
advisers, agents, alliance partners (“Relevant Persons”) or any other entity or person accepts any responsibility or liability
whatsoever for, or makes any representation, warranty or undertaking, express or implied, as to the truth, accuracy,
completeness or fairness of the information or opinions in this document (or whether any information has been omitted from
this document) or any other information relating to the Company, its subsidiaries or associated companies, whether written,
oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any
use of this document or its contents or otherwise arising in connection therewith. Accordingly, each Relevant Person disclaims,
to the fullest extent permitted by applicable law, all and any liability, whether arising in tort or contract or that they might
otherwise be found to have in respect of this document and/or any such statement.

This document does not constitute a prospectus. An offer to acquire Securities pursuant to the proposed offering will be made,
and any investor should make his investment, solely on the basis of information that will be contained in the prospectus to be
made generally available in Belgium in connection with such offering. When made generally available, copies of the
prospectus may be obtained at no cost from the Company or through the website of the Company.




Gimv NV - Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - www.gimv.com 4